Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine

On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non‐peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast‐growing phenomenon. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  K. Jansen.  Near death experience and the NMDA receptor. , 1989, BMJ.

[2]  H. Hays,et al.  Clinical experience with oral ketamine. , 1999, Journal of pain and symptom management.

[3]  Danielle C. Turner,et al.  Exploring the Impact of Ketamine on the Experience of Illusory Body Ownership , 2011, Biological Psychiatry.

[4]  K. Jansen.  Ketamine: Dreams and Realities , 2004 .

[5]  O. Corazza,et al.  Near-Death States Reported in a Sample of 50 Misusers , 2010, Substance use & misuse.

[6]  M. Farré,et al.  Psychoactive drug or mystical incense? Overview of the online available information on Spice products , 2009 .

[7]  J. Ramsey,et al.  Buying 'legal' recreational drugs does not mean that you are not breaking the law. , 2010, QJM : monthly journal of the Association of Physicians.

[8]  J. McVeigh,et al.  United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012. , 2013 .

[9]  J. Ramsey,et al.  Purchasing 'legal highs' on the Internet--is there consistency in what you get? , 2010, QJM : monthly journal of the Association of Physicians.

[10]  D. Gillatt,et al.  Recreational ketamine: from pleasure to pain , 2011, BJU international.

[11]  Fabrizio Schifano,et al.  Drugs on the web; the Psychonaut 2002 EU project , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Ornella Corazza.  Le nuove potenzialità della prevenzione digitale in materia di nuove droghe : il ruolo del Recreational Drugs European Network , 2010 .

[13]  Garry D. Honey,et al.  Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits , 2006, Trends in Cognitive Sciences.

[14]  I. Bonta,et al.  Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor. , 2004, Medical hypotheses.

[15]  P. Haggard,et al.  Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia , 2011, Cognitive neuropsychiatry.

[16]  Fabrizio Schifano,et al.  Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly. , 2011, Current clinical pharmacology.

[17]  P. Fletcher,et al.  Ketamine perturbs perception of the flow of time in healthy volunteers. , 2011, Psychopharmacology.

[18]  O. Corazza.  Exploring space consciousness and other dissociative experiences : A Japanese perspective , 2010 .

[19]  T. Tonia,et al.  Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006). , 2008, Journal of clinical psychopharmacology.

[20]  J. Copeland,et al.  Patterns of use and harms associated with non-medical ketamine use. , 2003, Drug and alcohol dependence.